Tatyana V. Novoselova

Tatyana V. Novoselova

Auto-generated profile, based on publicly available information

Tatyana V. Novoselova

Russian Academy of Sciences

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2005 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
TNTatiana V. Novoselova
Tatiana V. Novoselova
BMBoris A. Margulis
Boris A. Margulis
SNSergey S. Novoselov
Sergey S. Novoselov
ASAlexander M. Sapozhnikov
Alexander M. Sapozhnikov
JSJacqueline Van Der Spuy
Jacqueline Van Der Spuy
IGIrina V. Guzhova
Irina V. Guzhova

1 August 2009 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ENElena G Novoselova
Elena G Novoselova
SLSergey Lunin
Sergey Lunin
TNTatyana V. Novoselova
Tatyana V. Novoselova
MKMaxim O. Khrenov
Maxim O. Khrenov
OGOlga V Glushkova
Olga V Glushkova
EFEvgeny E. Fesenko
Evgeny E. Fesenko

1 March 2013 in Immunobiology
Verified
Journal Article
Open access
SLSergey Lunin
Sergey Lunin
OGOlga V Glushkova
Olga V Glushkova
MKM.O. Khrenov
M.O. Khrenov
TNT.V. Novoselova
T.V. Novoselova
SPS.B. Parfenyuk
S.B. Parfenyuk
ENElena G Novoselova
Elena G Novoselova
Modulation of autoimmune inflammation by the thymic peptides thymulin and thymopentin was studied in mice with acute experimental autoimmune encephalomyelitis (EAE), which resembles multiple sclerosis in humans. EAE was induced in NZW mice by a single immunisation with myelin basic protein coupled with adjuvants. Visible signs of pathology appeared on days 12-14 after the immunisation, peaked on days 20-25, were retained up to day 45, and then reverted. A biphasic cytokine response was also detected. In the "early" phase, which started at day 35, increased levels of interferon-gamma and interleukin-6 in the blood were observed; during the "delayed" phase, which started at day 48, the levels of plasma interleukin-17 and tumour necrosis factor-alpha were also raised. In addition, the phosphorylation of NF-kappaB signalling proteins and the production of heat shock protein Hsp72 were significantly increased in splenic lymphocytes from EAE-bearing mice. When applied intraperitoneally every other day for 30 days, either thymulin or thymopentin (15 μg per 100g of body weight) significantly reduced the disease severity compared to untreated EAE mice. The effect of thymulin but not thymopentin remained after its withdrawal. Thymulin reduced the cytokine response in both the early and the delayed phases, whereas thymopentin only reduced the "early phase cytokines" (IL-6 and interferon-gamma). Both peptides significantly reduced the level of phosphorylation of the NF-kappaB signalling protein IKK and the production of Hsp72 protein. The data presented here indicate the presence of time-dependent immune responses in EAE-bearing mice, which may be associated with the Th1 and Th17 subpopulations of T-cells. Thymulin and thymopentin demonstrated different patterns of activity, most likely via mechanisms involved in NF-kappa B signalling and Hsp72 expression.

1 January 2008 in Immunological Investigations
Verified
Journal Article
Closed access
SLSergey Lunin
Sergey Lunin
MKM. O. Khrenov
M. O. Khrenov
TNT. V. Novoselova
T. V. Novoselova
SPS. B. Parfenyuk
S. B. Parfenyuk
ENElena G Novoselova
Elena G Novoselova
The effects of synthetic analogue of peptide hormone thymulin, which is normally produced by thymic epithelial cells, on immune cells activity and blood cytokine profile had been studied in male NMRI mice with acute inflammation induced by injection of lipopolysaccharide from gram-negative bacteria (LPS, 250 μg/100 g of body weight). Inflammation induced by LPS resulted in accumulation of several plasma pro-inflammatory cytokines, IL-1β, IL-2, IL-6, TNF-α, interferon-γ, and also IL-10, anti-inflammatory cytokine. Thymulin previously injected in dose of 15 μg/100 g body weight, prevented the accumulation of proinflammatory cytokines in plasma. Thymulin also prevented LPS-induced up-regulation of production of several cytokines by spleen lymphocytes and peritoneal macrophages. Added in vitro, thymulin decreased the peak of TNF-α production in macrophages cultivated with LPS. In addition, thymulin lowered the peak of Hsp70 production induced by LPS treatment. The results indicate that thymulin having significant anti-inflammatory effect may be promising in clinical application.

20 October 2009 in Doklady Biological Sciences
Verified
Journal Article
Closed access
PDF file
ENElena G Novoselova
Elena G Novoselova
SLSergey Lunin
Sergey Lunin
MKM. O. Khrenov
M. O. Khrenov
TNT. V. Novoselova
T. V. Novoselova
EFE. E. Fesenko
E. E. Fesenko

13 June 2019 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
ENElena G Novoselova
Elena G Novoselova
OGOlga V Glushkova
Olga V Glushkova
SPS. B. Parfenuyk
S. B. Parfenuyk
MKM. O. Khrenov
M. O. Khrenov
SLSergey Lunin
Sergey Lunin
VNV. I. Novoselov
V. I. Novoselov
Taking into account a special role of pancreatic β-cells in the development of diabetes mellitus, the effects of peroxiredoxin 6 (Prx6) on the viability and functional activity of rat insulinoma...